Total Funding
75
69
Total FundingGrant raised
Growth Score
-7 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
12031
ProteinQure is a biotech company that designs peptide-based therapeutics and drug delivery systems with its proprietary AI platform.
- Tomas Babej: Cofounder & Chief Technology OfficerPast Role: Creative Destruction Lab, Enterpreneur in Training
Blaise Lippa: SAB MemberPast Role: Morphic Therapeutic, Sr. Vice President of Molecular Discovery
About the Company
ProteinQure is a biotech company focused on the design of novel exotic peptides with broad therapeutic applications. Powered by atomic-level simulations and artificial intelligence, it designs dynamic peptides to deliver drugs straight to their target sites. The company's lead therapeutic PQ203 for TOP1-resistant triple-negative breast cancer
entered Phase I trials in the US and Canada. The company has various anti-cancer drugs in its pipeline.
